Sitagliptin, a DPP-4 inhibitor, administered once- or twice-daily, provides substantial improvement in 24-hour glucose control in Japanese patients with type 2 diabetes mellitus (T2DM)

被引：0
|
作者：
Nonaka, Kenji
Tsubouchi, Hiroshi
Okuyama, Kotoba
Fukao, Yukako
Stein, Peter P.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A540 / A540
页数：1
相关论文
共 50 条
  • [31] Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
    Goldenberg, Ronald
    Gantz, Ira
    Andryuk, Paula J.
    O'Neill, Edward A.
    Kaufman, Keith D.
    Lai, Eseng
    Wang, Yin Na
    Suryawanshi, Shailaja
    Engel, Samuel S.
    DIABETES OBESITY & METABOLISM, 2017, 19 (03): : 394 - 400
  • [32] Clinically Differentiated Glucokinase Activator HMS5552: Effective Control of 24-Hour Glucose and Improvement of β-Cell Function in T2DM Patients
    Zhu, Dalong
    Ding, Yanhua
    Xiao, Dawei
    Fan, Hongwei
    Hu, Pei
    Li, Xiaoying
    Li, Yongguo
    Zhang, Yi
    Chen, Li
    DIABETES, 2015, 64 : A301 - A301
  • [33] Twelve-week efficacy and tolerability of sitagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, in Japanese patients with type 2 diabetes
    Nonaka, K.
    Kakikawa, T.
    Sato, A.
    Okuyama, K.
    Fujimoto, G.
    Hayashi, N.
    Suzuki, H.
    Hirayama, Y.
    Stein, P. P.
    DIABETOLOGIA, 2006, 49 : 25 - 26
  • [34] The Effect of DPP4 Inhibitor on Glycemic Variability in Patients with Type 2 Diabetes treated with twice-daily Premixed Human Insulin
    Tan, Florence Hui Sieng
    Tong, Chin Voon
    Lau, Bik Kui
    Kuan, Yueh Chien
    Loh, Huai Heng
    Pillai, Saravanan A. L. Vengadesa
    Tiong, Xun Ting
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2021, 36 (02): : 167 - 171
  • [35] Once-weekly DPP-4 inhibitors: The clinical efficacy and treatment satisfaction in 51 Japanese patients with type 2 diabetes mellitus
    Tosaki, Takahiro
    Kamiya, Hideki
    Himeno, Tatsuhito
    Kato, Yoshiro
    Kondo, Masaki
    Inagaki, Akemi
    Yamamoto, Yuka
    Tsubonaka, Kaori
    Oshiro, Chie
    Nakaya, Yuki
    Hayasaki, Tomoyo
    Nakamura, Jiro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S127 - S127
  • [36] Effects of dapagliflozin (DAPA), a sodium glucose cotransporter 2 inhibitor, on 24-hour glycaemic control in patients with type 2 diabetes
    Mansfield, T.
    Henry, R. R.
    Strange, P.
    Zhou, R.
    Zhuplatov, S. B.
    Klein, D.
    Katz, A.
    DIABETOLOGIA, 2016, 59 : S339 - S339
  • [37] Sitagliptin, a DPP-4 Inhibitor, Alters the Number and Proportion of the Subsets of Circulating CD4+T Cells in Patients with Type 2 Diabetes
    Aso, Yoshimasa
    Sagara, Masaaki
    Suzuki, Kunihiro
    Jojima, Teruo
    Iijima, Toshie
    Inukai, Toshihiko
    DIABETES, 2015, 64 : A324 - A325
  • [38] Clinically differentiated glucokinase activator HMS5552: effective control of 24-hour glucose and improvement of beta cell function in T2DM patients
    Zhu, Dalong
    Ding, Yanhua
    Xiao, Dawei
    Fan, Hongwei
    Hu, Pei
    Li, Xiaoying
    Li, Yongguo
    Zhang, Yi
    Chen, Li
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 : 11 - 11
  • [39] Twelve-week efficacy and tolerability of sitagliptin, a dipleptidyl peptidase-IV (DPP4) inhibitor, in Japanese patients with T2DM
    Nonaka, Kenji
    Kakikawa, Taro
    Sato, Asako
    Okuyama, Kotoba
    Fujimoto, Go
    Hayashi, Naoki
    Suzuki, Hideyo
    Hirayama, Yukio
    Stein, Peter
    DIABETES, 2006, 55 : A128 - A128
  • [40] Sitagliptin added to ongoing treatment with pioglitazone improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)
    Kashiwagi, Atsunori
    Tajima, Naoko
    Kadowaki, Takashi
    Nonaka, Kenji
    Moto, Tarooka
    Okuyama, Kotoba
    Nishii, Mikio
    Stein, Peter R.
    DIABETES, 2008, 57 : A590 - A590
12345